Glaukos Corporation develops innovative treatments for glaucoma, corneal disorders, and retinal diseases. Their products include micro-bypass stents inserted during cataract surgery and targeted injectable implants for delivering medication. Based in San Clemente, California, they sell their products directly and through distributors both in the US and worldwide.